DK1729746T3 - Anordning til transdermal administration af nikotin - Google Patents

Anordning til transdermal administration af nikotin

Info

Publication number
DK1729746T3
DK1729746T3 DK05708757.9T DK05708757T DK1729746T3 DK 1729746 T3 DK1729746 T3 DK 1729746T3 DK 05708757 T DK05708757 T DK 05708757T DK 1729746 T3 DK1729746 T3 DK 1729746T3
Authority
DK
Denmark
Prior art keywords
nicotine
transdermal administration
devices
well
administration
Prior art date
Application number
DK05708757.9T
Other languages
English (en)
Inventor
Eva Anette Katarina Lindell
Per Fredrik Nicklasson
Maarit Kristina Thyresson
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0400685A external-priority patent/SE0400685D0/xx
Application filed by Mcneil Ab filed Critical Mcneil Ab
Application granted granted Critical
Publication of DK1729746T3 publication Critical patent/DK1729746T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK05708757.9T 2004-03-19 2005-03-10 Anordning til transdermal administration af nikotin DK1729746T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0400685A SE0400685D0 (sv) 2004-03-19 2004-03-19 Means for transdermal administration of nicotine
US55887404P 2004-04-02 2004-04-02
PCT/IB2005/000673 WO2005089728A2 (en) 2004-03-19 2005-03-10 Means for transdermal administration of nicotine

Publications (1)

Publication Number Publication Date
DK1729746T3 true DK1729746T3 (da) 2010-03-08

Family

ID=34961693

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05708757.9T DK1729746T3 (da) 2004-03-19 2005-03-10 Anordning til transdermal administration af nikotin

Country Status (14)

Country Link
US (1) US20090130189A1 (da)
EP (1) EP1729746B1 (da)
AT (1) ATE448777T1 (da)
AU (1) AU2005224182B2 (da)
BR (1) BRPI0508894A (da)
CA (1) CA2559640C (da)
DE (1) DE602005017753D1 (da)
DK (1) DK1729746T3 (da)
ES (1) ES2334681T3 (da)
IL (1) IL177483A0 (da)
NZ (1) NZ549939A (da)
PL (1) PL1729746T3 (da)
RU (1) RU2334507C2 (da)
WO (1) WO2005089728A2 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080287507A1 (en) * 2007-05-16 2008-11-20 John Hedenstrom Nicotine containing toiletry waters
MX349292B (es) * 2008-11-18 2017-07-21 3M Innovative Properties Co Disposición de microagujas huecas y método.
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US9095503B2 (en) 2009-02-12 2015-08-04 Incube Labs, Llc System and method for biphasic transdermal iontophreotic delivery of therapeutic agents
US8903485B2 (en) 2009-08-06 2014-12-02 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US9017310B2 (en) 2009-10-08 2015-04-28 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including microneedles
US8882748B2 (en) 2009-10-08 2014-11-11 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including chemical permeation enhancers
US9014799B2 (en) 2009-10-08 2015-04-21 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including electrically-actuated permeation enhancement
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
AU2011200392B2 (en) * 2011-01-31 2015-05-28 Palo Alto Research Center Incorporated Transmucosal drug delivery device
WO2012154704A2 (en) 2011-05-06 2012-11-15 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US9005108B2 (en) 2012-09-27 2015-04-14 Palo Alto Research Center Incorporated Multiple reservoir drug delivery device and methods
US9999720B2 (en) 2012-09-27 2018-06-19 Palo Alto Research Center Incorporated Drug reconstitution and delivery device and methods
US9744341B2 (en) 2013-01-15 2017-08-29 Palo Alto Research Center Incorporated Devices and methods for intraluminal retention and drug delivery
CN109999335A (zh) * 2013-09-11 2019-07-12 因卡伯实验室有限责任公司 基于使用者吸入控制治疗剂的离子电渗递送的***和方法
US9297083B2 (en) 2013-12-16 2016-03-29 Palo Alto Research Center Incorporated Electrolytic gas generating devices, actuators, and methods
US10278675B2 (en) 2014-07-31 2019-05-07 Palo Alto Research Center Incorporated Implantable estrus detection devices, systems, and methods
US9801660B2 (en) 2014-07-31 2017-10-31 Palo Alto Research Center Incorporated Implantable fluid delivery devices, systems, and methods
GB2535427A (en) 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
US20180021563A1 (en) * 2015-03-09 2018-01-25 Koninklijke Philips N.V. Iontophoretic device, arrangement and method
US9974858B2 (en) 2015-08-29 2018-05-22 Medrx Co., Ltd Percutaneous absorption composition
WO2017037813A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 塩基性薬物とソルビン酸とを含有する経皮吸収組成物
US11571567B2 (en) * 2016-01-05 2023-02-07 Biosensor Laboratories Inc. Iontophoresis device for drug delivery and method for manufacturing the same

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901248A (en) * 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3877468A (en) * 1970-07-22 1975-04-15 Leo Ab Chewable tobacco substitute composition
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
GB8615676D0 (en) * 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US4943435A (en) * 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US5824334A (en) * 1989-09-05 1998-10-20 University Of Utah Research Foundation Tobacco substitute
US5230896A (en) * 1989-10-12 1993-07-27 Warner-Lambert Company Transdermal nicotine delivery system
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
US5167242A (en) * 1990-06-08 1992-12-01 Kabi Pharmacia Aktiebolaq Nicotine-impermeable container and method of fabricating the same
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
CA2123428A1 (en) * 1991-11-13 1993-05-27 John Corish Drug delivery device
US5756117A (en) * 1992-04-08 1998-05-26 International Medical Asscociates, Inc. Multidose transdermal drug delivery system
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US5415629A (en) * 1993-09-15 1995-05-16 Henley; Julian L. Programmable apparatus for the transdermal delivery of drugs and method
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
JPH10511008A (ja) * 1994-06-24 1998-10-27 シグナス， インコーポレイテッド 膜透過性制御のための電子電圧パルスを用いた生物学的活性因子のパルス使用送達システム
US5810081A (en) * 1997-02-24 1998-09-22 Cobb; Delwin E. Wear structure for bore hole separation device
US6447143B2 (en) * 1999-12-20 2002-09-10 Mark Howard Krietzman Flat credit card illuminator with flexible integral switching arm
WO2001064149A1 (en) * 2000-02-29 2001-09-07 Jie Zhang Improved transdermal drug patch
US20050118245A1 (en) * 2002-03-27 2005-06-02 Wilsmann Klaus M. Assembled unit consisting of individually separable, transdermal, therapeutic systems
DE60313216T2 (de) * 2002-12-20 2008-01-03 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose

Also Published As

Publication number Publication date
ES2334681T3 (es) 2010-03-15
AU2005224182A1 (en) 2005-09-29
CA2559640C (en) 2010-11-30
WO2005089728A2 (en) 2005-09-29
ATE448777T1 (de) 2009-12-15
CA2559640A1 (en) 2005-09-29
PL1729746T3 (pl) 2010-03-31
RU2334507C2 (ru) 2008-09-27
US20090130189A1 (en) 2009-05-21
NZ549939A (en) 2009-12-24
IL177483A0 (en) 2006-12-10
RU2006133118A (ru) 2008-04-27
BRPI0508894A (pt) 2007-09-11
EP1729746A2 (en) 2006-12-13
AU2005224182B2 (en) 2008-04-17
EP1729746B1 (en) 2009-11-18
DE602005017753D1 (de) 2009-12-31
WO2005089728A3 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
DK1729746T3 (da) Anordning til transdermal administration af nikotin
NO20053663D0 (no) Transdermal granistetron
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK2058020T3 (da) Indretning til indgivelse af lægemiddel
BRPI0718146A2 (pt) Dispositivos de infusão e métodos
ATE473744T1 (de) Modifizierte pyrimidin-glucocorticoid-rezeptor- modulatoren
NO20073482L (no) Fremgangsmåte til å stabilisere antidement medikament
DE602005022430D1 (de) Medizinproduktsysteme
TR200504892A1 (tr) Belirti göstermeyen tüberküloz tedavisi
NO20080622L (no) Disykloalkylurea-glukokinase aktivatorer
NL1029015A1 (nl) Therapeutische verbindingen.
CY1112582T1 (el) Διαδερμικη χορηγηση φεντανυλης
DK1830907T3 (da) Hætte til lægemiddelfrigivelsesanordninger
DK1833799T3 (da) 3-phenyl-pyrazol derivater, som modulatorer af 5-HT-2a-serotonin receptor nyttig til behandlingen af sygdomme relateret hertil
NO20080068L (no) Topisk unguale formuleringer
DK2114383T3 (da) Små-volumen orale transmukosale doseringsformer indeholdende sufentanil til behandling af smerte
NL1030220A1 (nl) Beveiliging van cryptografische communicatiesessies.
NO20073065L (no) Injiserbare nanopartikulaere olanzapinformuleringer
DK1868600T3 (da) Spirocyklisk cyclohexanderivat til behandling af stofafhængighed
NO20091299L (no) Substituerte sulfonamidderivater
DK1768728T3 (da) Tæller til inhalatoranordning
DK1750744T3 (da) Lægemiddel til behandling af svampeinfektioner, især aspergillose
DK1713438T3 (da) Medicinsk sæbe
ATE524167T1 (de) Transdermales pflaster
DE602004004453D1 (de) Stabile pharmazeutische zusammensetzungen mit desloratadine